Trials / Completed
CompletedNCT01258088
Safety Study of Ointment for the Treatment of Plaque-type Psoriasis
A Randomized, Double-blind, Vehicle-controlled, Multiple Cohort Study To Determine The Safety, Tolerability, And Pharmacokinetic Profile Of An2728 Ointment B, 2% In Healthy Volunteers And Patients With Mild-to-moderate Plaque-type Psoriasis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine how much drug is absorbed throughout the body after being applied to the skin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AN2728 Ointment | 5mg/cm2, BID |
| DRUG | AN2728 Vehicle | 5mg/cm2 BID |
Timeline
- Start date
- 2010-11-30
- Primary completion
- 2010-12-07
- Completion
- 2010-12-07
- First posted
- 2010-12-10
- Last updated
- 2019-03-05
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01258088. Inclusion in this directory is not an endorsement.